Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial and Strategic SWOT Analysis Review

Date: July 19, 2016
Pages: 40
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: JA805C133A3EN
Leaflet:

Download PDF Leaflet

Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial and Strategic SWOT Analysis Review
Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Jiangsu Hengrui Medicine Co., Ltd. (Jiangsu Hengrui) is a biopharmaceutical company that manufactures and distributes pharmaceutical products. Its product portfolio includes antineoplastic products; cardiovascular products; endocrine drugs; antibiotics; infusion products; and other products. The company has four research and development centers and production bases in Shanghai, Chengdu, Lianyungang and New Jersey. Jiangsu Hengrui’s R&D activities are focused at developing various new treatments. The company distributes its products in the domestic and international markets. The company has sales network throughout China in 32 provinces, autonomous regions and municipalities with numerous sales outlets and sales staff. Jiangsu Hengrui is headquartered in Lianyungang, Jiangsu Province, China.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

    Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

    Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

    Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

    Note: Some sections may be missing if data is unavailable for the company
  • SECTION 1 - ABOUT THE COMPANY

    Jiangsu Hengrui Medicine Co., Ltd. - Key Facts
    Jiangsu Hengrui Medicine Co., Ltd. - Key Employees
    Jiangsu Hengrui Medicine Co., Ltd. - Major Products and Services
    Jiangsu Hengrui Medicine Co., Ltd. - Pharmaceutical Pipeline Products Data
    Jiangsu Hengrui Medicine Co., Ltd., Pipeline Products by Therapy Area
    Jiangsu Hengrui Medicine Co., Ltd., Pipeline Products by Development Phase
    Jiangsu Hengrui Medicine Co., Ltd. - History
    Jiangsu Hengrui Medicine Co., Ltd. - Company Statement
    Jiangsu Hengrui Medicine Co., Ltd. - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries

    SECTION 2 – COMPANY ANALYSIS

    Jiangsu Hengrui Medicine Co., Ltd. - Business Description
    Jiangsu Hengrui Medicine Co., Ltd. - Corporate Strategy
    Jiangsu Hengrui Medicine Co., Ltd. - SWOT Analysis
    SWOT Analysis - Overview
    Jiangsu Hengrui Medicine Co., Ltd. - Strengths
    Strength - Focused Research and Development Activities
    Strength - Improved Pharmaceutical Manufacturing Segment Performance
    Jiangsu Hengrui Medicine Co., Ltd. - Weaknesses
    Weakness - Decline in Other Activities Segment
    Jiangsu Hengrui Medicine Co., Ltd. - Opportunities
    Opportunity - Strategic Agreements
    Opportunity - Market Potential: Chinese Pharmaceutical Market
    Opportunity - Changing Demographics
    Jiangsu Hengrui Medicine Co., Ltd. - Threats
    Threat - Uncertain R&D Outcomes
    Threat - Competitive Environment
    Threat - Government Regulations
    Jiangsu Hengrui Medicine Co., Ltd. - Key Competitors

    SECTION 3 – COMPANY FINANCIAL RATIOS

    Financial Ratios - Capital Market Ratios
    Financial Ratios - Annual Ratios
    Performance Chart
    Financial Performance
    Financial Ratios - Interim Ratios
    Financial Ratios - Ratio Charts

    SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

    Jiangsu Hengrui Medicine Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Jiangsu Hengrui Medicine Co., Ltd., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Jiangsu Hengrui Medicine Co., Ltd., Recent Deals Summary

    SECTION 5 – APPENDIX

    Methodology
    Ratio Definitions
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Jiangsu Hengrui Medicine Co., Ltd., Key Facts
    Jiangsu Hengrui Medicine Co., Ltd., Key Employees
    Jiangsu Hengrui Medicine Co., Ltd., Major Products and Services
    Jiangsu Hengrui Medicine Co., Ltd., Number of Pipeline Products by Therapy Area
    Jiangsu Hengrui Medicine Co., Ltd., Number of Pipeline Products by Development Stage
    Jiangsu Hengrui Medicine Co., Ltd., Pipeline Products By Therapy Area and Development Phase
    Jiangsu Hengrui Medicine Co., Ltd., History
    Jiangsu Hengrui Medicine Co., Ltd., Subsidiaries
    Jiangsu Hengrui Medicine Co., Ltd., Key Competitors
    Jiangsu Hengrui Medicine Co., Ltd., Ratios based on current share price
    Jiangsu Hengrui Medicine Co., Ltd., Annual Ratios
    Jiangsu Hengrui Medicine Co., Ltd., Interim Ratios
    Jiangsu Hengrui Medicine Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Jiangsu Hengrui Medicine Co., Ltd., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Jiangsu Hengrui Medicine Co., Ltd., Recent Deals Summary
    Currency Codes
    Capital Market Ratios
    Equity Ratios
    Profitability Ratios
    Cost Ratios
    Liquidity Ratios
    Leverage Ratios
    Efficiency Ratios

    LIST OF FIGURES

    Jiangsu Hengrui Medicine Co., Ltd., Pipeline Products by Therapy Area
    Jiangsu Hengrui Medicine Co., Ltd., Pipeline Products by Development Phase
    Jiangsu Hengrui Medicine Co., Ltd., Performance Chart (2011 - 2015)
    Jiangsu Hengrui Medicine Co., Ltd., Ratio Charts
    Jiangsu Hengrui Medicine Co., Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Jiangsu Hengrui Medicine Co., Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
    Skip to top


    Ask Your Question

    Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial and Strategic SWOT Analysis Review
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: